Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
44 studies found for:    Open Studies | "Living Donors"
Show Display Options
Rank Status Study
21 Unknown  Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes
Condition: Renal Transplantation
Intervention: Drug: TAIZ
22 Not yet recruiting Comparison of Postoperative Outcome of Hepatectomy for Living Donors According to Three Different Incision
Condition: Healthy Donors for Liver Transplantation
Interventions: Procedure: hepatectomy conventional incision;   Procedure: hepatectomy midline incision;   Procedure: hepatectomy transverse incision
23 Recruiting MIC Cell Therapy for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients
Condition: Kidney Failure, Chronic
Intervention: Biological: Mitomycin C-induced peripheral blood mononuclear cells (MICs)
24 Recruiting House Calls and Decision Support: Improving Access to Live Donor Transplantation
Conditions: Chronic Kidney Disease;   End-Stage Renal Disease
Interventions: Behavioral: House Calls;   Behavioral: Web-Based Patient-Centered Decision Support Intervention
25 Unknown  Adult-to-Adult Living Donor Transplant Cohort Study
Conditions: Liver Diseases;   Hepatocellular Cancer;   End Stage Liver Disease;   Hepatitis C;   Liver Cirrhosis
Intervention:
26 Recruiting Effects of Sevoflurane and Desflurane on Treg
Condition: Transplant; Failure, Kidney
Interventions: Drug: Sevoflurane;   Drug: Desflurane
27 Unknown  Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch
Condition: Kidney Failure, Chronic
Intervention: Drug: Thymoglobulin
28 Unknown  Prospective Tacrolimus Pharmacokinetics Study in Pediatric Living Donor Liver Transplantation
Condition: Pediatric Liver Transplantation
Intervention: Drug: Tacrolimus
29 Not yet recruiting Propofol Versus Dexmedetomidine for Prevention of Sevoflurane Agitation in Recipients of Living Donor Liver Transplantation
Condition: Liver Transplantation
Interventions: Drug: Propofol;   Drug: dexmedetomedine
30 Recruiting A Comparison of Propofol Based Total Intravenous Anesthesia and Desflurane Based Balanced Anesthesia on Hepatic Protection During Living-donor Liver Transplantation
Condition: End Stage Liver Disease
Interventions: Drug: Desflurane balanced anesthesia;   Drug: Propofol total intravenous anesthesia
31 Recruiting RituxiMab INDuction in Renal Transplantation
Condition: Function of Renal Transplant
Interventions: Drug: Rituximab;   Drug: Tacrolimus;   Drug: Mycophenylate mofetil;   Drug: Hydrocortisone;   Drug: Prednisolone
32 Recruiting Mesenchymal Stromal Cells in Kidney Transplant Recipients
Condition: Kidney Transplant Rejection
Intervention: Biological: Mesenchymal Stromal Cells
33 Recruiting Quantifying Steatosis in Liver Transplant Donors
Conditions: Non-alcoholic Fatty Liver Disease;   Evidence of Liver Transplantation
Intervention:
34 Unknown  Adrenal Function After Living Kidney Donation
Conditions: Addison Disease;   Hypoaldosteronism
Intervention: Procedure: Laparoscopic hand-assisted donor nephrectomy
35 Recruiting Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs
Condition: Immune Tolerance
Intervention: Device: Immune tolerance
36 Recruiting Pre-formed Alloreactivity in Renal Transplant Recipients
Conditions: Kidney Transplantation;   Acute Graft Rejection
Intervention:
37 Recruiting Lipids and Neurological Complications in Liver Transplantation
Condition: Neurological Complications
Intervention: Drug: SMOF lipid (SMOFLIPID) pre treatment
38 Recruiting Omega 3 Lipid Emulsions and Liver Transplantation
Condition: Ischemia Re-perfusion Injury
Interventions: Dietary Supplement: SMOFLipid;   Dietary Supplement: equivalent volume of 10% glucose solution
39 Recruiting The ONE Study ATDC Trial
Condition: Renal Failure, End Stage
Intervention: Biological: ATDC_Nantes
40 Unknown  Trial of Rituximab Given Pre-Transplant to Sensitised Live Donor Kidney Recipients
Condition: Kidney Transplantation
Interventions: Drug: Rituximab;   Drug: Standard Care

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-44) Show next page of results    Last Page
Indicates status has not been verified in more than two years